These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 22273692)

  • 41. [Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control].
    Bocher V; Chinetti G; Fruchart JC; Staels B
    J Soc Biol; 2002; 196(1):47-52. PubMed ID: 12134632
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Peroxisome proliferator-activated receptors: A key link between lipid metabolism and cancer progression.
    Li Y; Pan Y; Zhao X; Wu S; Li F; Wang Y; Liu B; Zhang Y; Gao X; Wang Y; Zhou H
    Clin Nutr; 2024 Feb; 43(2):332-345. PubMed ID: 38142478
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PPARs and their metabolic modulation: new mechanisms for transcriptional regulation?
    Ahmed W; Ziouzenkova O; Brown J; Devchand P; Francis S; Kadakia M; Kanda T; Orasanu G; Sharlach M; Zandbergen F; Plutzky J
    J Intern Med; 2007 Aug; 262(2):184-98. PubMed ID: 17645586
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lipolytic PPAR activation: new insights into the intersection of triglycerides and inflammation?
    Ziouzenkova O; Plutzky J
    Curr Opin Clin Nutr Metab Care; 2004 Jul; 7(4):369-75. PubMed ID: 15192437
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Peroxisomal fatty acid metabolism, peroxisomal proliferator-activated receptors and non-alcoholic fatty liver disease.
    Macdonald GA; Prins JB
    J Gastroenterol Hepatol; 2004 Dec; 19(12):1335-7. PubMed ID: 15610304
    [No Abstract]   [Full Text] [Related]  

  • 46. Elucidating the Beneficial Role of PPAR Agonists in Cardiac Diseases.
    Khuchua Z; Glukhov AI; Strauss AW; Javadov S
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400386
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Lipid metabolism related nuclear receptor--the structure, function, expression and classification of peroxisome proliferation-activated receptor (PPAR)].
    Kawada T
    Nihon Rinsho; 1998 Jul; 56(7):1722-8. PubMed ID: 9702044
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Autoimmune disease].
    Yoshikawa T; Kawahito Y
    Nihon Rinsho; 2005 Apr; 63(4):687-90. PubMed ID: 15828238
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Roles of PPARs on regulating myocardial energy and lipid homeostasis.
    Yang Q; Li Y
    J Mol Med (Berl); 2007 Jul; 85(7):697-706. PubMed ID: 17356846
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation.
    Castrillo A; Tontonoz P
    Annu Rev Cell Dev Biol; 2004; 20():455-80. PubMed ID: 15473848
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PPARs: therapeutic targets for metabolic disease.
    Berger JP; Akiyama TE; Meinke PT
    Trends Pharmacol Sci; 2005 May; 26(5):244-51. PubMed ID: 15860371
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of PPARs in modulating cardiac metabolism in diabetes.
    Holness MJ; Samsuddin S; Sugden MC
    Pharmacol Res; 2009 Sep; 60(3):185-94. PubMed ID: 19376230
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The metabolic syndrome: relationship between insulin sensitivity and the role of peroxisome proliferator-activated receptors (PPARs) in saccharide and lipid metabolism.
    Yahia RB; Lichnovská R; Brychta T
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):237-41. PubMed ID: 16601762
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Recent advances in PPARs research--basic and clinical aspects].
    Kadowaki T
    Nihon Rinsho; 2005 Apr; 63(4):539-48. PubMed ID: 15828218
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The selected pathophysiological aspects of PPARs activation.
    Kieć-Wilk B; Dembińska-Kieć A; Olszanecka A; Bodzioch M; Kawecka-Jaszcz K
    J Physiol Pharmacol; 2005 Jun; 56(2):149-62. PubMed ID: 15985699
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors.
    Gervois P; Fruchart JC; Staels B
    Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):145-56. PubMed ID: 17237841
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Peroxisome proliferator-activated receptors: bridging metabolic syndrome with molecular nutrition.
    Guri AJ; Hontecillas R; Bassaganya-Riera J
    Clin Nutr; 2006 Dec; 25(6):871-85. PubMed ID: 17052808
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Peroxisome proliferator-activated receptors (PPARs) and ovarian function--implications for regulating steroidogenesis, differentiation, and tissue remodeling.
    Komar CM
    Reprod Biol Endocrinol; 2005 Aug; 3():41. PubMed ID: 16131403
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The roles of peroxisome proliferator-activated receptors in the metabolic syndrome.
    Mansour M
    Prog Mol Biol Transl Sci; 2014; 121():217-66. PubMed ID: 24373239
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Anti-inflammatory action of PPARs].
    Fujii H
    Nihon Rinsho; 2005 Apr; 63(4):609-15. PubMed ID: 15828228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.